Table 3 PAE efficacy outcomes after 3 and 12 months

IPSS

20.7 ± 5.7

2.3 ± 2.2

−18.4 (− 88.7%)

2.8 ± 3.8

−17.9 (− 86.6%)

< 0.001

QoL

5.4 ± 0.5

1.3 ± 1.8

−4.1 (− 75.9%)

1.1 ± 1.1

−4.3 (− 79.4%)

< 0.001

PV (cm³)

112.5 ± 35.4

75.8 ± 29.9

− 36.7 (− 32.6%)

69.3 ± 37.1

− 43.2 (− 38.4%)

< 0.001

Qmax (ml/s)

6.6 ± 6.2

22.5 ± 19.8

+ 15.8 (+ 238.0%)

19.9 ± 7.5

+ 13.3 (+ 199.4%)

0.006

PSA (ng/ml)

6.1 ± 2.8

2.2 ± 1.7

− 3.9 (− 64.9%)

3.0 ± 2.4

− 3.0 (− 50.1%)

< 0.001